Found: 50
Select item for more details and to access through your institution.
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4243, doi. 10.1007/s00432-022-04287-5
- By:
- Publication type:
- Article
Central nervous systemic efficacy of immune checkpoint inhibitors and concordance between intra/extracranial response in non-small cell lung cancer patients with brain metastasis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4523, doi. 10.1007/s00432-022-04251-3
- By:
- Publication type:
- Article
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 11, p. 3025, doi. 10.1007/s00432-020-03293-9
- By:
- Publication type:
- Article
Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 7, p. 1897, doi. 10.1007/s00432-019-02941-z
- By:
- Publication type:
- Article
Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 8, p. 1775, doi. 10.1007/s00432-016-2196-2
- By:
- Publication type:
- Article
Real-world data analysis of patients with cancer of unknown primary.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02543-1
- By:
- Publication type:
- Article
Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99197-w
- By:
- Publication type:
- Article
Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 413, doi. 10.1016/j.clgc.2023.12.012
- By:
- Publication type:
- Article
The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
- Published in:
- International Journal of Hematology, 2015, v. 102, n. 3, p. 357, doi. 10.1007/s12185-015-1830-0
- By:
- Publication type:
- Article
Current Status and Future Direction in the Treatment of Advanced Adrenocortical Carcinoma.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 4, p. 307, doi. 10.1007/s11912-024-01510-z
- By:
- Publication type:
- Article
Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients.
- Published in:
- Annals of Laboratory Medicine, 2021, v. 41, n. 2, p. 207, doi. 10.3343/alm.2021.41.2.207
- By:
- Publication type:
- Article
ASO Visual Abstract: Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7279, doi. 10.1245/s10434-021-10122-x
- By:
- Publication type:
- Article
An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma.
- Published in:
- PLoS ONE, 2023, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0287256
- By:
- Publication type:
- Article
A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1239, doi. 10.1007/s10637-019-00817-0
- By:
- Publication type:
- Article
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 721, doi. 10.4143/crt.2023.1043
- By:
- Publication type:
- Article
Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 785, doi. 10.4143/crt.2023.1014
- By:
- Publication type:
- Article
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer: Single-Institution Experience.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 774, doi. 10.4143/crt.2023.1177
- By:
- Publication type:
- Article
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 2, p. 404, doi. 10.4143/crt.2023.784
- By:
- Publication type:
- Article
Clinical Outcomes of Small Cell Carcinoma of the Genitourinary Tract and the Prognostic Significance of the Tumor Immune Microenvironment.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 2, p. 624, doi. 10.4143/crt.2023.1076
- By:
- Publication type:
- Article
Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 468, doi. 10.4143/crt.2022.1342
- By:
- Publication type:
- Article
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in KRAS-Mutant Non–Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 767, doi. 10.4143/crt.2021.651
- By:
- Publication type:
- Article
The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 226, doi. 10.4143/crt.2021.365
- By:
- Publication type:
- Article
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 1, doi. 10.4143/crt.2021.1115
- By:
- Publication type:
- Article
Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1549, doi. 10.4143/crt.2019.086
- By:
- Publication type:
- Article
Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 6, p. 995, doi. 10.1007/s00277-014-2015-2
- By:
- Publication type:
- Article
A unique pattern of extranodal involvement in Korean adults with sporadic Burkitt lymphoma: a single center experience.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 12, p. 1917, doi. 10.1007/s00277-012-1531-1
- By:
- Publication type:
- Article
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22–09
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12338-y
- By:
- Publication type:
- Article
Suicide in cancer patients within the first year of diagnosis.
- Published in:
- Psycho-Oncology, 2015, v. 24, n. 5, p. 601, doi. 10.1002/pon.3705
- By:
- Publication type:
- Article
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations.
- Published in:
- JNCI Cancer Spectrum, 2024, v. 8, n. 3, p. 1, doi. 10.1093/jncics/pkae030
- By:
- Publication type:
- Article
Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 120, doi. 10.3390/cancers13010120
- By:
- Publication type:
- Article
Epidemiology and Outcomes of Non–Small Cell Lung Cancer in South Korea.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e2355331, doi. 10.1001/jamanetworkopen.2023.55331
- By:
- Publication type:
- Article
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 3, p. 705, doi. 10.1002/cam4.4476
- By:
- Publication type:
- Article
Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 10, p. 3197, doi. 10.1002/cam4.3874
- By:
- Publication type:
- Article
Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231546
- By:
- Publication type:
- Article
Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0221065
- By:
- Publication type:
- Article
Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteria.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00624-0
- By:
- Publication type:
- Article
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access program.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1403120
- By:
- Publication type:
- Article
Pneumatosis Intestinalis After Cetuximab-containing Chemotherapy for Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 10, p. 1225, doi. 10.1093/jjco/hyr114
- By:
- Publication type:
- Article
Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA)
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 309, doi. 10.1007/s00280-014-2638-y
- By:
- Publication type:
- Article
Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 1, p. 182, doi. 10.1007/s10120-015-0580-2
- By:
- Publication type:
- Article
Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 3, p. e211136, doi. 10.1001/jamanetworkopen.2021.1136
- By:
- Publication type:
- Article
Clinical Implication of Serine Metabolism-Associated Enzymes in Colon Cancer.
- Published in:
- Oncology, 2015, v. 89, n. 6, p. 351, doi. 10.1159/000439571
- By:
- Publication type:
- Article
CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
- Published in:
- Cellular Oncology (2211-3428), 2019, v. 42, n. 4, p. 449, doi. 10.1007/s13402-019-00434-2
- By:
- Publication type:
- Article
A new model using deep learning to predict recurrence after surgical resection of lung adenocarcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-56867-9
- By:
- Publication type:
- Article
Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 6045, doi. 10.2147/OTT.S213928
- By:
- Publication type:
- Article